Bristol-Myers Squibb Company BMY
$ 58.19
0.52%
Quarterly report 2024-Q3
added 10-31-2024
Bristol-Myers Squibb Company DSO Ratio 2011-2024 | BMY
Annual DSO Ratio Bristol-Myers Squibb Company
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
84.4 | 76.1 | 70.3 | 69.5 | 107 | 96.5 | 111 | 104 | 94.8 | 77.9 | 74.8 | 63.9 | 64.3 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
111 | 63.9 | 84.2 |
Quarterly DSO Ratio Bristol-Myers Squibb Company
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
86.1 | 81.8 | 79.8 | 84.9 | 82 | 80.2 | - | 39.1 | 32.7 | 70 | - | 71.7 | 68.9 | 70.7 | 70.1 | 73.6 | 76.6 | 68.5 | 88.3 | 117 | 112 | 104 | 89.5 | 95.6 | 95.4 | 108 | 106 | 109 | 112 | 110 | 96.5 | 103 | 104 | 102 | 91.5 | 96.4 | 94.2 | 86.8 | 72.7 | 78.9 | 79.5 | 80.8 | 69 | 75.4 | 75.7 | 76.7 | 67.1 | 75.3 | 63.3 | 59.3 | 62.6 | 63.9 | 62.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
117 | 32.7 | 82.7 |